Randomised Controlled Trial of Sublingual and Rectal Misoprostol in the Prevention of Primary Postpartum Haemorrhage in a Resource-Limited Community
Open Access
- 29 June 2020
- journal article
- research article
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 70 (6) , 462-470
Abstract
Background/Purpose Misoprostol is beneficial in preventing postpartum haemorrhage (PPH). However, there is no consensus yet as to which route will give the balance of efficacy, safety and patient preference, especially at the recommended dose of 600 mcg. This study compared the efficacy and adverse effects of rectal and sublingual misoprostol for the prevention of PPH. Methods In a prospective fashion, consenting eligible parturients were randomised into two groups to receive either 600 mcg of misoprostol rectally or sublingually after vaginal delivery. All study participants were followed up till 24 h postpartum. Primary outcomes were blood loss of 500 ml or greater and at least 10% change in peripartum haematocrit levels. Results Seven (6.7%) and 16 (15.7%) of the sublingual and rectal routes, respectively, had PPH. However, the odds of having PPH after rectal misoprostol were at least twice the odds after the sublingual route (p = 0.041). Also, the mean blood loss after the first, fourth and 24th hour postpartum were significantly higher after rectal administration. Although significantly more patients had shivering and pyrexia after sublingual misoprostol, it was acceptable to more participants than the rectal route. Conclusion At the recommended dose, sublingually administered misoprostol (‘the sweet of life’) is associated with a lower incidence of PPH than the rectal route. Despite its higher incidence of shivering and pyrexia, it was accepted by more women than rectally administered misoprostol. ClinicalTrials.gov identifier PACTR201911500348367.Keywords
This publication has 27 references indexed in Scilit:
- Prostaglandins for preventing postpartum haemorrhageCochrane Database of Systematic Reviews, 2012
- Emergency peripartum hysterectomy in Nnewi, Nigeria: A 10-year reviewNigerian Journal of Clinical Practice, 2012
- Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?Global Health Action, 2011
- The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual dosesBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trialBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Postpartum Hemorrhage: Epidemiology, Risk Factors, and CausesClinical Obstetrics & Gynecology, 2010
- Measurement of Blood Loss: Review of the LiteratureJournal of Midwifery & Women's Health, 2010
- Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effectsBulletin of the World Health Organization, 2009
- Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of laborInternational Journal of Gynecology & Obstetrics, 2009
- Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effectsInternational Journal of Gynecology & Obstetrics, 2007